Is Neuralstem flirting with noncompliance via a Right To Try Law in Colorado? Colorado is an independent-minded state. For example, it is one of only a few states including Washington State with legalized marijuana use. More recently, Colorado passed a new law supported by the ultra-conservative Goldwater Institute, the so-called Right To Try Law. This law […]
Neuralstem flirting with noncompliance via Right To Try Law? Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »
ISSCR and I held a short essay contest for a free registration to ISSCR 2014 in Vancouver. The winning piece was written by student Mohamed Gatie, but there was a great 2nd place essay by Sherry Hikita that deserved acknowledgment. I’m publishing that essay below and Sherry will be receiving a free signed copy of my book and a free stem cell
Great 2nd Place ISSCR Essay Related to Vision and Stem Cells Read More »
The future is now. Or so goes the expression. For CIRM, it rings true today. Last year I blogged about what we might expect from the new CIRM that would evolve and take form in the future. I was particularly thinking about this coming incarnation of CIRM, which I called CIRM 2.0, as it related
Welcome CIRM 2.0 and President Mills Read More »
Late last year I was hearing some exciting things about California Stem Cell, Inc. under the leadership of Hans Keirstead. (2020 update: interestingly 3 years ago Keirstead ran for congress, but the campaign didn’t quite make it.) In fact, I thought a big move for California Stem was in the cards for 2014 and looking into
As Predicted, Big News For California Stem Cell, Inc.: Purchased by NeoStem Read More »
Very small embryonic-like stem cells aka VSELs are reported to be tiny adult stem cells that are pluripotent or non-existent depending on whom you talk to most recently or which paper you just read. These very controversial cells (which I once compared to the Sasquatch) have a wildly fluctuating history with their existence on multiple occasions
Wild History of VSELs Predicts Future of STAP Cells? Read More »
The Alabama Institute of Medicine (AIM) is one of the great success stories in the stem cell research field. It’s an extraordinary achievement as a state stem cell agency. Below I’ve interviewed one of AIM’s founders and its Vice President, Tory Williams. Above you can see a picture of Tory with Roman Reed at the
Interview with Tory Williams of Amazing Alabama Institute of Medicine (AIM) Read More »
Advanced Cell Technology (ACT; $ACTC) has a new paper out on using human embryonic stem cells (hESC) to make MSCs with potentially powerful therapeutic potential. The paper, entitled Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties, was published in the journal Stem Cells and Development. What’s the scoop on this
Review of New ACT Paper on hESC-derived MSCs Read More »
An FDA committee began a meeting yesterday that continues today to consider permitting new assisted reproduction-based “3-parent” technology that could address mitochondrial disorders, a serious human health problem. The technology also raises complex health issues of its own and invokes ethical questions. The goal of the FDA meeting is articulated this way: “the committee will
Why the FDA should not green-light 3-parent reproduction Read More »
What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time
Interview with Robert Klein on CIRM’s Future Read More »